Course contact details
Admissions
Email:ask@herts.ac.uk
Phone:01707 284800
University of Hertfordshire
College Lane
Hatfield
AL10 9AB
The use of the immune system in cancer therapy is a prevailing ambition in the field. You’ll gain expert knowledge of the numerous ways cancers and the immune system interact so you can learn how cancer immunotherapies are developed. We’ll provide a thorough understanding of immune effector mechanisms and cancer biology. You’ll develop a range of personal skills through self-directed learning and our problem-based approach to teaching.
Why choose this course?
You’ll be taught by our expert staff and innovative speakers from the biopharmaceutical industry
Our modern Science Building provides excellent facilities for laboratory experiments, including DNA and genomic analysis eg QPCR, protein and proteomic science (eg MALDI-ToF), cell culture and Enzyme-based assays, isolated tissue studies and immunohistochemistry
When you graduate, you’ll be equipped to work in a broad range of fields including medical or pharmaceutical research and development, clinical trials, public health and epidemiology, academia research, medical writing and science journalism, education, or patent law
We adopt a blended learning approach to teaching, focussing on problem-based scenarios so you can develop strong critical analysis skills. You’ll benefit from exposure to practical techniques and guaranteed laboratory-based research projects.
If successful, you will have the opportunity to undertake an extended 12-month research project.
Discover what it's like to study Cancer Immunotherapy with Advanced Research at University of Hertfordshire: insights on the course, making friends, personal statement tips, uni prep, and recommended books, podcasts, and videos.
Select a course option at the top of this page to view entry requirement information.
Choose a specific option to see funding information.
Course optionsEmail:ask@herts.ac.uk
Phone:01707 284800
College Lane
Hatfield
AL10 9AB
At University of Hertfordshire